The b2-adrenergic receptor (ADRB2) plays a major role in regulating energy expenditure by stimulating lipid metabolism in human adipose tissue. Polymorphisms in the ADRB2 gene have been associated with obesity and various weightrelated traits in cross-sectional studies of adults, but little is known about the effects of the ADRB2 gene on childhood obesity or the propensity to gain weight over time. OBJECTIVE: To assess the effects of a polymorphism in codon 16 (Arg16?Gly) of the ADRB2 gene, which has been associated with a decrease in b2-receptor density and efficiency, on longitudinal changes in obesity from childhood to young adulthood in a biracial cohort. DESIGN: Seven cross-sectional screenings of children and five cross-sectional screenings of young adults who were previously examined as children produced longitudinal data from childhood to young adulthood. METHODS: Height, weight and subscapular and triceps skinfolds were measured by trained examiners following identical protocols over the course of the study. Gender-and age-stratified analyses using random coefficients models were used to examine longitudinal genetic effects on obesity in 1151 African-American and Caucasian males and females who attended an average of six examinations over a 24 y period from childhood to young adulthood. RESULTS: Age-stratified analyses showed no clear genetic relationships with changes in obesity measures over time in females, but an age-dependent association was observed in males, where the relationship between the Arg16Gly polymorphism and obesity became stronger with age. In males who were 4 -9 y of age at the beginning of the study in 1973, body mass index (BMI) was 4% higher in Gly=Gly and Arg=Gly males compared to those with Arg=Arg by 26 y of age. Subscapular skinfold measurements in Gly=Gly males became significantly different from Arg=Arg males (20% higher) by age 20. In the oldest male cohort (10 -14 y of age in 1973), BMI increased at a significantly greater rate (0.4%=y) in males carrying the Gly16 form of the receptor relative to Arg=Arg males. BMI was significantly different between homozygous genotypes by approximately 26 y of age, and reached 8% higher in Gly=Gly males by age 32. Subscapular skinfolds also increased at a significantly greater rate (2%=y) in Gly=Gly males compared to Arg=Arg males, becoming significantly different (27%) by approximately 22 y of age and reaching a maximum difference of 50% by age 32. CONCLUSIONS: Our data suggest that the b2-adrenergic receptor is associated with the propensity to gain weight from childhood to young adulthood in males. An increased understanding of genetic influences on the development of obesity may improve the effectiveness of interventions designed to reduce excess body weight and help define the role of genetic factors in diabetes and cardiovascular disease.
Background
Obesity has been increasing markedly in both children and adults over the past two decades. Approximately 50 -60% of the adult population in the USA, Canada, and Europe are now overweight (body mass index; BMI ! 25 kg=m 2 ) or obese (BMI ! 30 kg=m 2 ), 1 and developing countries have begun to experience significant increases in the prevalence of obesity. 2 The dramatic increase in obesity and overweight is having a major negative impact on public health, because obesity and body fat distribution are established risk factors for noninsulin-dependent diabetes and chronic cardiovascular diseases such as atherosclerosis, hypertension and stroke. 3 Long-term consequences of obesity in childhood have not been well studied, but longitudinal studies suggest that overweight children and adolescents are at increased risk of becoming obese adults with adverse cardiovascular risk profiles. 4, 5 Changes in obesity and body fat over time may be partially attributable to behavioral and environmental influences such as unhealthy diet and low levels of physical activity, but genetic factors also affect changes in adiposity that often occur with increasing age. 6, 7 Genes controlling body fat storage and energy expenditure are believed to be important in the development of obesity. Catecholamines stimulate lipolysis in fat cells through a family of G proteincoupled receptors known as the b-adrenergic receptors, which regulate thermogenesis, resting metabolic rate, and energy balance, and thus may influence variation among individuals in relative body weight. 8 The b2-adrenergic receptor (ADRB2) plays a major role in regulating energy expenditure by stimulating lipid metabolism in human adipose tissue and may function in the ability to control or maintain body weight over time. Polymorphisms in the ADRB2 gene have been associated with obesity and various weight-related traits in cross-sectional studies of adults, but little is known about the effects of the ADRB2 gene on childhood obesity or the propensity to gain weight over time.
In this study, we investigated relationships between the ADRB2 Arg16Gly polymorphism and longitudinal changes in adiposity, measured by BMI and subscapular and triceps skinfolds, from childhood to young adulthood in participants of the Bogalusa Heart Study. We hypothesized that individuals carrying the Gly16 form of the receptor, previously shown to decrease b2-receptor density and efficiency, would be more likely to become obese than individuals carrying the Arg16 form due to less efficient stimulation of lipolysis and excess fat accumulation over time.
Methods

Study population
The Bogalusa Heart Study is a long-term epidemiologic study of the early natural history of cardiovascular disease in children and young adults from the biracial community of Bogalusa, Louisiana. From 1973 to 1996, seven cross-sectional screenings of children, and five cross-sectional screenings of young adults who were previously examined as children, were conducted. Repeated cross-sectional examinations conducted approximately every 3 y produced longitudinal data from childhood to adulthood. Individuals 21 -38 y of age who participated as children in earlier examinations beginning in 1973 were eligible for this study. Participants were excluded if ADRB2 genotype data were unavailable (13 males, 16 females). All participants gave informed consent approved by the Institutional Review Board of the Tulane University Medical Center.
General examinations
All examinations over the course of the study used trained examiners and followed identical protocols. 9 Interviews with participants were conducted to assess demographic factors including age, gender, smoking status, cardiovascular history and medication use. Blood was collected in vacutainers containing EDTA from the antecubital vein of seated subjects and stored frozen at 7 70 C until used for genomic DNA isolation. Height was measured to the nearest 0.1 cm and weight to the nearest 0.1 kg on subjects wearing light clothing. The means of two independent measurements for height and weight were used to calculate BMI (kg=m 2 ).
10
Subscapular and triceps skinfolds were each measured three times to the nearest 1 mm and mean thickness at each site was used in the analyses. Intraclass correlation coefficients, assessed from 10% rescreening in all examinations, were 0.99 for height, weight and BMI, and > 0.98 for skinfold measurements.
ADRB2 genotyping
Genomic DNA was isolated from whole blood by a saltchloroform extraction procedure. 11 Genotyping of the ADRB2 Arg16Gly polymorphism was performed using the TaqMan assay. 12 A 121 bp product was amplified by PCR with 0.9 mM each of the forward 5 0 -CGGCAGCGCCTTCTTG-3 0 and reverse 5 0 -GGCCAGGACGATGAGAGACA-3 0 primers, 30 ng genomic DNA, 5.0 mM MgCl 2 , and 1ÂTaqMan universal PCR master mix containing AmpliTaq Gold DNA polymerase in a 22 ml reaction volume. Products were amplified using initial incubation steps of 2 min at 50 C and 10 min at 95 C to activate the AmpliTaq Gold, followed by 40 cycles of 15 s at 95 C and 1 min at 62 C. Aliquots (0.2 mM) of the allele-specific probes 5 0 -6FAM-CTGGCACCCAATA-GAAGCCATGC-TAMRA-3 0 and 5 0 -VIC-CTGGCACCCAATG-GAAGCCATG-TAMRA-3 0 were hybridized to the target DNA in a sequence-specific manner. Allele discrimination and genotyping were conducted by detecting the fluorescent signals of the reporter dyes on an ABI 7700 using Sequence Detection System software (Applied Biosystems). All laboratory personnel were blind to the identification of individual samples. Quality of the data was assessed by blind duplicate 
Statistical analysis
Gender-and age-stratified analyses were conducted to accommodate differences in growth and development between males and females from childhood through young adulthood. 13 From the total sample of 1337 individuals in 999 sibships, unique family members were selected within gender groups by preferential inclusion of the sibling attending the largest number of examinations. After excluding 186 siblings, 1151 participants (494 males, 657 females) who attended an average of six examinations since 1973 were included in this study.
Chi-square analyses were used to test the distributions of ADRB2 genotypes within ethnic groups for conformance to Hardy -Weinberg equilibrium, to assess allele and genotype frequency differences between ethnic and gender groups, and to compare allele frequencies between Bogalusa Heart Study participants with those observed in other African American and Caucasian populations.
14 Longitudinal genetic effects on obesity measures, which were log-transformed to reduce skewness, were examined separately in males and females using a random coefficients (multi-level modeling) approach. Random coefficients models allow for repeated measurements on subjects, accommodate different numbers of unequally spaced observations across individuals, and permit modeling of within-and between-individual variability. 15, 16 A random coefficients model allows the intercept and slope parameter to vary from individual to individual and the random coefficients represent the difference between an overall parameter and the true value for the individual. The basic form for the random coefficients model when examining the relationship between a dependent variable and time is:
where a 0 is the overall intercept, m i is the difference between the overall intercept and the true intercept for the ith subject, b 0 is an overall slope parameter, and t i is the difference between the overall slope and the true slope in the ith subject. T ij is the jth time point in the ith subject, C i represents a vector of covariates associated with the ith subject, and e ij is the jth residual or error term in the ith subject. The model assumes m i and t i are generated from bivariate normal distributions with means of zero, variances of s 2 m and s 2 t , respectively, and covariance of s mt . If the dependent variable of interest has a 'higher order' polynomial relationship over time, additional fixed and random terms can be added to the model. Participants were assigned to birth cohorts by extrapolating age reported at the first attended examination to 1 January 1973. The distribution of ages on 1 January 1973 varied from 7 3 to 14 y of age and participants were assigned to the following cohorts to accommodate secular trends in adiposity 17 and to derive adequate numbers for analysis: newborn cohort ( 7 3 -3 y of age), childhood cohort (4 -9 y of age), teenage cohort (10 -14 y of age). A cohort-stratified analysis considering males and females separately was conducted because the shape of gender-and cohort-specific plots of the longitudinal data differed considerably. Plots of the longitudinal data suggested a basic model, which was then evaluated by considering additional terms sequentially to determine a final model for each cohort. The basic model consisted of an indicator variable for race, age on 1 January 1973 in years, ADRB2 genotype as a categorical variable, follow-up time relative to 1 June 1984 (centered follow-up time) up to a cubic term, and terms for interaction between the linear follow-up time variable and race, age in 1973, and genotype. The intercept, linear follow-up time, and quadratic follow-up time variables were specified as random coefficients with a multivariate normal distribution, and thus were allowed to vary for each subject. Additional terms (cubic follow-up time as a random coefficient, race by follow-up time interaction, and race by genotype interaction) were considered, but not retained, in any genderspecific cohort model (P > 0.05). After the final model was determined to be appropriate for each cohort, an alternative diagonal variance-covariance matrix (uncorrelated random coefficients) was tested by a likelihood ratio test. Model assumptions were checked visually by inspecting residual and bivariate plots of the random coefficients. 18 All statistical analyses considered a P-value < 0.05 statistically significant and were conducted using SAS version 6.12.
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Results
ADRB2 genotype and allele frequencies
Genotype and allele frequency distributions in Bogalusa Heart Study participants are presented in Table 1 . Genotype frequencies within ethnic groups did not deviate from Hardy -Weinberg expectations (African-Americans, P ¼ 0.609; Caucasians, P ¼ 0.529). Both genotype (P < 0.001) and allele (P < 0.001) frequencies differed significantly between ethnic groups; the Gly16 allele was more frequent and the Arg16 allele was less frequent in Caucasians relative to African-Americans. Neither genotype nor allele frequencies differed significantly between genders (P ¼ 0.695 for genotype proportions; P ¼ 0.814 for allele proportions). Allele frequencies in Bogalusa African-Americans did not differ from those observed in another African-American population from Nashville, Tennessee (P ¼ 0.910), but allele frequencies in Bogalusa Caucasians differed significantly from those in Caucasians from the Nashville community (P < 0.001). 20 
Longitudinal analysis
In a preliminary analysis, age-adjusted means were calculated by gender, cohort and ADRB2 genotype for BMI and (Table 3) . The final random coefficients model for each cohort in both males and females was identical to the basic model because all additional terms examined were not significant at the 0.05 level. Parameter estimates from the random coefficients models for all males considered together before partitioning into birth cohorts suggest that BMI and subscapular skinfolds increased over time at a greater rate in individuals carrying Gly=Gly and Arg=Gly genotypes than in males with Arg=Arg genotypes, but this difference was only marginally significant (P < 0.10; Table 4 ). Stratifying by birth cohort revealed an age-dependent effect, where genetic influences on obesity became stronger with age. No genotype effects on BMI, subscapular skinfolds, or triceps skinfolds were observed in the newborn cohort. In the childhood cohort, BMI increased approximately 0.2% more per year in males with Gly=Gly and Arg=Gly genotypes than in those with Arg=Arg. This rate of change indicates that by 26 y of age, Gly=Gly and Arg=Gly males had BMI values 4% higher than males with Arg=Arg. In the oldest (teenage) cohort, BMI in males with Gly=Gly and Arg=Gly genotypes increased at a significantly greater rate (0.4%=y) than in Arg=Arg males, which translates to an 8% higher BMI by age 32. Statistically significant divergence in BMI in the teenage cohort was detected at approximately 26 y of age (Figure 1) .
Results for subscapular skinfolds were similar to those for BMI (Table 4 ). In the childhood cohort, Gly=Gly and Arg=Gly males had higher baseline subscapular skinfolds and these measures increased at a higher annual rate (although not statistically significant) than in Arg=Arg individuals. Statistically significant divergence was detected by age 20, when Gly=Gly males had subscapular skinfolds more than 20% higher than Arg=Arg males. In the teenage cohort, subscapular skinfolds in Gly=Gly males increased at a significantly greater rate (2%=y) than in Arg=Arg males and significant divergence (27%) was apparent by approximately 22 y of age ( Figure 2 ). No genotype effect was detected for triceps skinfolds in any birth cohort (data not shown).
In females, genetic effects on longitudinal changes in obesity measures were not detected in the childhood and teenage cohorts. In the newborn cohort, baseline BMI and skinfold measurements tended to be greater in females carrying the Arg=Arg genotype than in Arg=Gly or Gly=Gly females; however, Arg=Gly and Gly=Gly females exhibited significantly greater rates of change over time. As a result, no significant differences in obesity measures were observed at any point in time in the newborn cohort (data not shown).
Discussion
Obesity is influenced by multiple behavioral, environmental, and genetic factors. Several studies have shown that physical inactivity, increased caloric intake, parental obesity, and gender are predictive of increased BMI and body fat development in preadolescent and adolescent children, 21 -23 but few studies have examined the influence of genetic variation on weight gain from childhood to adulthood. Longitudinal studies in twins suggest that genetic factors have a greater a Genotype and allele frequencies differ significantly by race (P < 0.001).
Longitudinal change in obesity DL Ellsworth et al Longitudinal change in obesity DL Ellsworth et al influence on obesity than behavior or environment in younger age groups 24 and that independent genetic contributions to obesity occur throughout middle age. 25 Although genetic variation has been associated with obesity and body weight among people of all ages in cross-sectional studies, little is known about the influence of specific genes and genetic polymorphisms on the development of obesity over time.
The ADRB2 Arg16Gly polymorphism and longitudinal change in obesity The b2-adrenergic receptor regulates energy expenditure by stimulating the metabolism (breakdown) of fat in adipose tissue, and therefore, may play an important role in the development of human obesity. Numerous cross-sectional studies have examined relationships between functional polymorphisms in the ADRB2 gene and a variety of obesity-related phenotypes. The Arg16Gly polymorphism has not been widely studied in relation to obesity, but available evidence suggests that Arg16Gly is not associated with obesity in European women 26, 27 and Japanese men, 28 although limited evidence suggests a possible association in Japanese women. 29 The ADRB2 Arg16Gly polymorphism occurs in the extracellular N-terminus and is believed to regulate b2 receptor function. The Gly16 form has been associated with lower receptor density, and hence reduced efficiency, compared with the Arg16 form, which may influence the propensity to gain weight in early adulthood. Individuals carrying the Gly16 allele (Gly16 homozygotes in particular) may be more likely to become obese than Arg16 homozygotes because b2 receptor density may be much lower in Gly16 carriers due to enhanced down-regulation. 30 Down regulation of the b2 receptor may lead to less efficient stimulation of lipolysis in adipose tissue and excess fat accumulation over time.
The ADRB2 Arg16Gly polymorphism and weight gain in males We observed differences in obesity measures between Gly=Gly and Arg=Arg genotypes that became more pronounced with age as well as significant interactions with time in African-American and Caucasian males, but did not observe similar relationships in females. Other studies have found significant associations between the glutamine (Gln)?glutamic acid (Glu) substitution at codon 27 and increased risk of obesity in men but not in women, 31 or observed conflicting associations between men and women. 26, 32 Differences between men and women in the propensity to gain weight are likely complex, but may be influenced by mechanisms of lipolysis in adipose tissue and hormonal effects on adrenergic receptor activity.
The accumulation of fat in subcutaneous and visceral adipose tissue is a common feature of obesity in men and Longitudinal change in obesity DL Ellsworth et al women, but men are prone to accumulate fat in the abdominal (upper body) region, whereas, women accumulate fat in the lower body (gluteal-femoral) regions. 33 The distribution and affinity of adrenergic receptors on human adipocytes are believed to play an important role in lipid metabolism and may contribute to differences in fat distribution between genders. Lipolysis is controlled by a number of cell surface receptors, including the b1-, b2-and b3-adrenergic receptors as well as the a2-adrenergic receptors. Activation of the breceptors stimulates lipolysis (triglycerides are hydrolyzed to glycerol and free fatty acids), while activation of a2-receptors inhibits lipolysis.
Studies of response to adrenergic receptor agonists have shown that (1) function of the a2-receptors is greater in abdominal adipose tissue of men compared to women (testosterone may enhance abdominal a2-receptor activity), Figure 1 Predicted longitudinal change in body mass index (BMI) from 1973 to 1996 by b 2 -adrenergic receptor genotype for male participants of the Bogalusa Heart Study. Participants were assigned to one of three cohorts based on their age on 1 January 1973: newborn cohort, 7 3 -3 y of age (top panel); childhood cohort, 4 -9 y of age (middle panel); teenage cohort, 10 -14 y of age (bottom panel). Predictions were derived separately for each cohort using random coefficients regression models. The 95% confidence interval is given for each curve at selected time points.
Longitudinal change in obesity DL Ellsworth et al which may partially explain the tendency of men to accumulate fat in the abdominal region, and (2) the b-adrenergic receptors found in abdominal adipose tissue are 10 -20-fold more sensitive than the b-receptors in gluteal-femoral tissue. 34 Increased receptor function may be attributable to a higher density and=or enhanced efficiency of the a-and b-receptors in abdominal tissue, and may cause abdominal adipocytes to be more responsive to the lipolytic effects of catecholamines. 35 The Arg16 to Gly mutation in the ADRB2 gene, associated with lower receptor function due to enhanced down-regulation, may have a greater influence on the propensity to gain weight in males than females. The Gly16 form of the b2-receptor may inhibit lipolysis to a greater degree in Figure 2 Predicted longitudinal change in subscapular skinfolds from 1979 to 1996 by b 2 -adrenergic receptor genotype for male participants of the Bogalusa Heart Study. Participants were assigned to one of three cohorts based on their age on 1 January 1973: newborn cohort, 7 3 -3 y of age (top panel); childhood cohort, 4 -9 y of age (middle panel); teenage cohort, 10 -14 y of age (bottom panel). Predictions were derived separately for each cohort using random coefficients regression models. The 95% confidence interval is given for each curve at selected time points.
Longitudinal change in obesity DL Ellsworth et al abdominal adipose tissue (where b-receptor density= efficiency is higher) than in gluteal -femoral tissue and males carrying the Gly16 allele may be unable to compensate effectively due to higher abdominal a2-receptor efficiency, which also inhibits lipolysis. In women, the ADRB2 polymorphism may not be associated with weight gain over time because lower a2-receptor sensitivity in abdominal adipose tissue may allow women to compensate for any reduction in lipolysis efficiency attributable to the Arg16 to Gly mutation.
Secular trends and implications for intervention and prevention
Background studies of obesity in the Bogalusa community have shown that the prevalence of overweight in school children and young adults increased approximately 2-fold in African-American and Caucasian males and females between 1973 and 1994. 17 Similar to trends nationwide, these secular trends in obesity appear to be accelerating, with the largest increases occurring since 1983 in young adults 19 -24 y of age. 36 The recent increases in the prevalence of obesity in children and young adults are likely attributable to behavioral=environmental factors such as high fat diets and decreased levels of physical activity rather than genetic factors, 22 which may influence the ability to detect genetic influences on the development of obesity. For example, associations between the Arg16Gly polymorphism and weight gain were strongest in the teenage cohort, evident but weaker in the childhood cohort, and absent in the youngest (newborn) cohort. We cannot determine whether the association between the b2-receptor and weight gain will become more apparent as these cohorts age or if secular trends will obscure genetic influences on obesity.
Results of this study have important implications for weight control intervention and prevention programs. For males carrying the Gly16 allele who may be at increased risk for obesity in adulthood, beneficial lifestyle changes such as a low fat diets and increased levels of physical activity, or pharmacologic interventions if implemented in childhood, may be most effective in preventing obesity once these individuals reach adulthood. Interactions between environmental factors responsible for secular trends in obesity and genetic influences on weight gain are unclear at present but represent important areas for future research.
